Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
10
×
Tags
biotech
10
×
deals
10
×
national blog main
vc
10
×
life sciences
startups
san diego blog main
san francisco blog main
boston blog main
national top stories
new york blog main
san diego top stories
boston top stories
venture capital
new york top stories
san francisco top stories
cancer
gene therapy
ipo
san diego
seattle blog main
avalon ventures
boston
correlation ventures
detroit blog main
eli lilly
funding
healthcare
hemophilia
indiana blog main
innovation
laura shawver
medical device
medical devices
medicxi
medtech
orbimed
ra capital management
raleigh-durham blog main
rtw investments
What
based
developing
drugs
healthcare
million
new
raise
san
startup
advance
biology
biotech
capital
cytokine
device
enhanced
firm
fund
gene
medicines
patients
plans
raised
revealed
suite
synthetic
synthorx
therapy
today
venture
ventures
week
additional
additions
aiming
aims
ambys
approach
arrhythmia
backing
Language
unset
Current search:
vc
×
deals
×
photo
×
biotech
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
30Ventures Seeks $15M to Fund Startups in Healthcare, Water Tech
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs